SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

SVB Leerink Maintains Outperform on Translate Bio, Raises Price Target to $30

SVB Leerink analyst Geoffrey Porges maintains Translate Bio (NASDAQ:TBIO) with a Outperform and raises the price target from $21 to $30.

Benzinga · -
SVB Leerink analyst Geoffrey Porges maintains Translate Bio (NASDAQ: TBIO) with a Outperform and raises the price target from $21 to $30.